Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
10/28/2022 |
Director
Trans History: 127
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 16,000 | $44.00 | 32,020 |
02/11/2011 |
Chief Executive Officer
Trans History: 123
|
Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 16,000 | -- | 52,687 |
02/11/2011 |
Chief Executive Officer
Trans History: 123
|
Chief Executive Officer | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 16,000 | -- | 52,761 |
02/23/2012 |
Chief Executive Officer
Trans History: 123
|
Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,800 | -- | 69,315 |
08/3/2022 |
Director, Chief Executive Officer
Trans History: 305
|
Director, Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | $40.95 | 91,597 |
08/12/2020 |
President
Trans History: 123
|
President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | $27.14 | 112,403 |
08/9/2019 |
Chief Executive Officer
Trans History: 123
|
Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | $37.27 | 113,915 |
08/20/2018 |
Chief Executive Officer
Trans History: 123
|
Chief Executive Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 15,000 | $48.63 | 105,921 |
08/16/2018 |
Chief Executive Officer
Trans History: 123
|
Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | $48.65 | 120,921 |
07/31/2017 |
Chief Executive Officer
Trans History: 123
|
Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | $40.44 | 117,055 |
Pagination
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.